Norgine Europe B.V


Jamieson is pleased to announce that it has advised the management team of Norgine Europe B.V. (“Norgine”) on the sale of the business to Goldman Sachs Asset Management.

Norgine is a leading European specialty pharmaceutical company with a diversified, differentiated portfolio of approximately 40 products. Norgine’s offering comprises the iconic MOVICOL brand with 25+ years’ heritage, a growing portfolio of promoted prescription products across both launch and growth stages, and a high-quality and differentiated pipeline, offering growth opportunities across multiple therapeutic areas. The Company has a proven track record developing, acquiring, and in-licensing assets, levering its fully integrated operations, which include a pan-European infrastructure and strong regulatory, market access, and launch capabilities.

Stuart Coventry, Stephen Maxwell and Henry Balcerak advised the Norgine management team on the transaction.